Akorn, Inc. has signed a commercial manufacturing supply agreement with GeneraMedix, Inc. to manufacture injectable products in finished dosage form for GeneraMedix. Under the agreement, GeneraMedix will market these products in the GeneraMedix label. The agreement includes products currently available from Akorn, as well as select injectable products from the Akorn internal product development pipeline. Arthur S. Przybyl, president and chief executive officer of Akorn stated, “We a...